Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.

Artículos de revista /

Anticancer Res. 2014 Apr;34(4):1959-66. Juan O1, Sánchez-Hernández A, Vázquez S, Casal J, Firvida JL, Aparisi F, Muñoz J, García-Sánchez J, Gironés R,

Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study. Leer más »

Juan O1 et al.
Ver

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile.

Artículos de revista /

Anticancer Drugs. 2014 Apr;25(4):368-74. Vázquez S1, Lázaro M, Fírvida JL, Santomé L, Afonso J, Amenedo M, Casal J; Galician Lung Cancer Group

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile. Leer más »

Vázquez S1 et al.
Ver

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

Artículos de revista /

Cancer Chemother Pharmacol. 2014 Mar;73(3):451-7. Casal Rubio J1, Fírvida-Pérez JL, Lázaro-Quintela M, Barón-Duarte FJ, Alonso-Jáudenes G, Santomé L, Afonso-Afonso FJ, Amenedo M,

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study. Leer más »

C. Rubio J1 et al.
Ver